We’ve had to make this difficult decision in order to protect vital NHS services and also to test ways of delivering this new ...

CEO of UnitedHealthcare shot and killed in New York; More snow predicted for hard-hit Great Lakes region; New study compares the effectiveness of popular weight loss drugs; and more on tonight’s ...

A study of two popular weight loss drugs, Zepbound and Wegovy, found that Zepbound was more effective helping people lose ...

Kelly Clarkson showed off her killer holiday style at the annual Rockefeller Christmas tree lighting, wearing a stunning ...

Amid the war on obesity, a clear winner has emerged in a battle between two weight-loss injectables. Zepbound (tirzepatide), ...

Leptin by itself doesn't hold promise for weight loss — but a new mouse study suggests it could work in combination with ...

More than half of Americans qualify for GLP-1 receptor agonist drugs, but many can't afford them. Experts share cheaper ...

Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has outperformed its main competitor, Wegovy, in a clinical ...

Zepbound, a drug with the main active ingredient tirzepatide, was found to be more helpful in helping people lose weight than ...

Participants in Wegovy clinical trials were more likely to report “severe gastrointestinal adverse reactions,” the FDA's ...

Adults who take Zepbound lose more weight than those who take competitor weight loss drug Wegovy, according to new clinical ...

Ozempic promotes weight loss by mimicking the GLP-1 hormone the body naturally produces after eating, so users feel fuller ...